News Research Ethics, Regulation, and Responsible Use

AACE 2026: Will AI replace endocrinologists?

April 22, 2026 By Jared Bilski 3 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
Objective:

To explore the impact of AI on the role of endocrinologists in patient care and the need for adaptation.

Key Findings:
  • 14 million clinic visits in the U.S. were canceled in one month due to AI use.
  • Patients often arrive with AI-generated misinformation, complicating consultations.
  • AI tools can improve patient-physician relationships when used thoughtfully, enhancing understanding and empathy.
Interpretation:

AI is reshaping patient interactions and care delivery in endocrinology, presenting both challenges and opportunities that require careful management by clinicians.

Limitations:
  • AI-generated information may lack context and accuracy.
  • The reliance on AI could lead to misinformation among patients, but it also has the potential to enhance care when used responsibly.
Conclusion:

Endocrinologists are unlikely to be replaced by AI, but they must adapt to its integration in patient care and guide its development responsibly to ensure patient safety and care quality.

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content